Australia's Clinuvel Pharmaceuticals gains on product launch

Clinuvel Pharmaceuticals

01/03/2023 24:44

** Shares of Clinuvel Pharmaceuticals Ltd  CUV.AX  rise as
much as 4.8% to A$20.0
    ** The pharmaceutical co says it has launched first of its
four healthcare product lines with a polychromatic screen for
protection from ultraviolet light named 'CYACÊLLE'
    ** Co says it has developed the world's first systemic
photoprotective pharmaceutical named 'SCENESSE'
    ** CUV says 'SCENESSE' is for treating patients intolerant
to light due to genetic disease erythropoietic protoporphyria
    ** Stock down ~12% this year, as of last close
 

 (Reporting by Ayushman Ojha in Bengaluru)
 ((Ayushman.ojha@thomsonreuters.com;))